NO20055923L - Farmasoytisk anvendbare salter av karboksylsyrderivater - Google Patents

Farmasoytisk anvendbare salter av karboksylsyrderivater

Info

Publication number: NO20055923L
Authority: NO; Norway
Prior art keywords: carboxylic acid; acid derivatives; pharmaceutically usable; usable salts; salts
Prior art date: 2003-06-18

Application number

NO20055923A

Other languages

English (en)

Norwegian (no)

Inventor

Erica Stahle

Ralf Ragnar

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-18

Filing date

2005-12-13

Publication date

2006-01-06

2005-12-13 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-01-06 Publication of NO20055923L publication Critical patent/NO20055923L/no

Links

150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
VFYAWARECOZRBD-VWLOTQADSA-N (2s)-2-ethoxy-3-[4-[2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy]phenyl]propanoic acid Chemical compound C=1C=C(C[C@H](OCC)C(O)=O)C=CC=1OCC(=O)N(CCCCCC)CCC1=CC=CC=C1 VFYAWARECOZRBD-VWLOTQADSA-N 0.000 abstract 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
229910052791 calcium Inorganic materials 0.000 abstract 1
239000011575 calcium Substances 0.000 abstract 1
159000000003 magnesium salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20055923A 2003-06-18 2005-12-13 Farmasoytisk anvendbare salter av karboksylsyrderivater NO20055923L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0314136.3A GB0314136D0 (en)	2003-06-18	2003-06-18	Therapeutic agents
PCT/SE2004/000965 WO2004110985A1 (en)	2003-06-18	2004-06-16	Pharmaceutically useful salts of carboxylic acid derivates

Publications (1)

Publication Number	Publication Date
NO20055923L true NO20055923L (no)	2006-01-06

Family

ID=27636795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055923A NO20055923L (no)	2003-06-18	2005-12-13	Farmasoytisk anvendbare salter av karboksylsyrderivater

Country Status (21)

Country	Link
US (1)	US20060194879A1 (pt)
EP (1)	EP1638921A1 (pt)
JP (1)	JP3836498B1 (pt)
KR (1)	KR20060017646A (pt)
CN (1)	CN1805922A (pt)
AR (1)	AR044802A1 (pt)
AU (1)	AU2004247611A1 (pt)
BR (1)	BRPI0411455A (pt)
CA (1)	CA2527608A1 (pt)
CO (1)	CO5650229A2 (pt)
GB (1)	GB0314136D0 (pt)
IL (1)	IL172168A0 (pt)
IS (1)	IS8232A (pt)
MX (1)	MXPA05013713A (pt)
NO (1)	NO20055923L (pt)
RU (1)	RU2005138369A (pt)
SA (1)	SA04250170B1 (pt)
TW (1)	TW200503678A (pt)
UY (1)	UY28371A1 (pt)
WO (1)	WO2004110985A1 (pt)
ZA (1)	ZA200510199B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0229931D0 (en) *	2002-12-21	2003-01-29	Astrazeneca Ab	Therapeutic agents
GB0314079D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
SE0104333D0 (sv)	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
JP3782818B2 (ja)	2002-06-20	2006-06-07	アストラゼネカアクチボラグ	インスリン抵抗性の処置のためのオルト置換安息香酸誘導体
WO2007004957A1 (en) *	2005-07-05	2007-01-11	Astrazeneca Ab	Novel crystalline form
AR055073A1 (es) *	2005-07-11	2007-08-01	Astrazeneca Ab	Agentes terapeuticos
FR2903985B1 (fr)	2006-07-24	2008-09-05	Sanofi Aventis Sa	Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2904316B1 (fr)	2006-07-31	2008-09-05	Sanofi Aventis Sa	Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
UY30648A1 (es) *	2006-10-20	2008-05-02	Janssen Pharmaceutica Nv	Formas salinas de compuestos de benzotienilo sustituido

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20020060067A (ko) *	1999-04-06	2002-07-16	가와무라 요시부미	α-치환 카르복실산 유도체
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents

2003
- 2003-06-18 GB GBGB0314136.3A patent/GB0314136D0/en not_active Ceased
2004
- 2004-06-09 TW TW093116599A patent/TW200503678A/zh unknown
- 2004-06-16 SA SA04250170A patent/SA04250170B1/ar unknown
- 2004-06-16 KR KR1020057024066A patent/KR20060017646A/ko not_active Withdrawn
- 2004-06-16 AU AU2004247611A patent/AU2004247611A1/en not_active Abandoned
- 2004-06-16 CA CA002527608A patent/CA2527608A1/en not_active Abandoned
- 2004-06-16 CN CNA2004800168384A patent/CN1805922A/zh active Pending
- 2004-06-16 US US10/560,127 patent/US20060194879A1/en not_active Abandoned
- 2004-06-16 JP JP2006517040A patent/JP3836498B1/ja not_active Expired - Fee Related
- 2004-06-16 EP EP04736956A patent/EP1638921A1/en not_active Withdrawn
- 2004-06-16 WO PCT/SE2004/000965 patent/WO2004110985A1/en not_active Ceased
- 2004-06-16 RU RU2005138369/04A patent/RU2005138369A/ru not_active Application Discontinuation
- 2004-06-16 MX MXPA05013713A patent/MXPA05013713A/es not_active Application Discontinuation
- 2004-06-16 BR BRPI0411455-8A patent/BRPI0411455A/pt not_active IP Right Cessation
- 2004-06-17 AR ARP040102112A patent/AR044802A1/es not_active Application Discontinuation
- 2004-06-17 UY UY28371A patent/UY28371A1/es not_active Application Discontinuation
2005
- 2005-11-24 IL IL172168A patent/IL172168A0/en unknown
- 2005-12-13 NO NO20055923A patent/NO20055923L/no not_active Application Discontinuation
- 2005-12-14 ZA ZA200510199A patent/ZA200510199B/en unknown
- 2005-12-28 CO CO05130776A patent/CO5650229A2/es unknown
2006
- 2006-01-13 IS IS8232A patent/IS8232A/is unknown

Also Published As

Publication number	Publication date
GB0314136D0 (en)	2003-07-23
CN1805922A (zh)	2006-07-19
JP2006527767A (ja)	2006-12-07
IS8232A (is)	2006-01-13
RU2005138369A (ru)	2007-07-27
KR20060017646A (ko)	2006-02-24
ZA200510199B (en)	2006-12-27
IL172168A0 (en)	2009-02-11
AU2004247611A1 (en)	2004-12-23
CO5650229A2 (es)	2006-06-30
US20060194879A1 (en)	2006-08-31
SA04250170B1 (ar)	2007-10-29
UY28371A1 (es)	2005-01-31
TW200503678A (en)	2005-02-01
MXPA05013713A (es)	2006-06-27
WO2004110985A1 (en)	2004-12-23
CA2527608A1 (en)	2004-12-23
AR044802A1 (es)	2005-10-05
EP1638921A1 (en)	2006-03-29
BRPI0411455A (pt)	2006-07-18
JP3836498B1 (ja)	2006-10-25

Legal Events

Date	Code	Title	Description
2009-02-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
FR25C1030I2 (fr)	2026-02-06	Sels de lysine de derives d'acide 4-((phenoxyalkyl) thio)-phenoxyacetique
CY1124753T1 (el)	2022-07-22	Συνθεση ενωσεων βορονικων εστερων και οξεων
NO20055923L (no)	2006-01-06	Farmasoytisk anvendbare salter av karboksylsyrderivater
AR070357A1 (es)	2010-03-31	Producto para cuidado oral y metodos de uso y manufactura del mismo
MA29416B1 (fr)	2008-04-01	Inhibiteurs d'age
CR8218A (es)	2007-09-14	Antidoto sobre la base de derivados de acidos carboxilicos aromaticos alifaticos
MA32961B1 (fr)	2012-01-02	Sel hemifumarate d'acide 1-[4-[1(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl]-2-ethyl -benzyl]-azetidine-3-carboxylique
CR20120526A (es)	2013-03-11	Proceso para la preparación de 4-{4[({[4-cloro-3-(trifluorometilo)-fenilo] amino} carbonilo) amino]-3-fluorofenoxi}-n-metilpiridino-2-carboxamida, sus sales y monohidrato
NO20073755L (no)	2007-08-28	Ibandronatpolymorf B
MY148953A (en)	2013-06-14	Substituted biphenyl carboxylic acids and derivatives thereof
MX2008010884A (es)	2008-09-03	Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1.
SV2010003770A (es)	2011-05-20	Composicion y proceso- 356
NO20055922L (no)	2006-01-06	Farmasoytiske anvendbare salter av karboksylsyrderivater
EA200900707A1 (ru)	2010-04-30	Новый способ синтеза 7,8-диметокси-1,3-дигидро-2h-3-бензазепин-2-она, и его применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
PL362366A1 (en)	2004-04-05	New method of industrial synthesis of tetra esters of 5-[bis(carboxyl methyl)amino]-3 -karboxymethyl-4-cyano-2-tio phenokarboxylic acid, method of manufacture of divalent salts of ranelic acid and their hydrates, as well as new intermediate compounds
CR10989A (es)	2010-03-01	Sales de adicion de acido, hidratos y polimorfos de la etil-amida del acido 5-(2,4-dihidroxi-5-isopropil-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxilico, y formulaciones que comprenden estas formas
DE602006000874D1 (de)	2008-05-21	Wässrige Zusammensetzungen enthaltend Salze von Perfluoropolyether Dicarbonsäuren zur ölabstossenden Papierleimung
TNSN08517A1 (en)	2010-04-14	Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4¬phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
SE0201661D0 (sv)	2002-05-31	New salts
SE0403072D0 (sv)	2004-12-16	Pharmaceutically useful salts of carboxylic acid derivates
DE502006009412D1 (de)	2011-06-09	Matrixkontrolliertes transdermales system mit salzen der ace-hemmer-dicarbonsäuren
ATE438611T1 (de)	2009-08-15	Verfahren zum herstellen von racemischem 3- hydroxy-3-(2-phenylethyl)-hexansäureester
MX2010004261A (es)	2010-04-30	Acidos carboxilicos bifenil y derivados de los mismos.
TH81758A (th)	2006-12-14	เกลือของอนุพันธ์คาร์บอกซิลิคแอซิดที่มีประโยชน์ในทางเภสัชกรรม
TH69770A (th)	2005-07-26	สารรักษาโรค